Routine coagulation molecules predict nasopharyngeal carcinoma and associated metastases

References

• Petersson F Nasopharyngeal carcinoma: a review. Seminars Diagnostic Pathol. 2015;32:54–73.
   PubMed Web of Science ®Google Scholar
• Riaz N, Tam M, Lee N. Nasopharyngeal carcinoma. Surg Oncol Clin North Am. 2015;24:547–561.
   PubMed Web of Science ®Google Scholar
• Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol. 1998;16:1310–1317.
   PubMed Web of Science ®Google Scholar
• Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol. 2002;3:27–34.
   PubMed Web of Science ®Google Scholar
• Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol. 2009;27:4839–4847.
   PubMed Web of Science ®Google Scholar
• Peng PH, Wu CC, Liu SC, et al. Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma. J Proteomics. 2011;74:744–757.
   PubMed Web of Science ®Google Scholar
• Vavilala MS, Dunbar PJ, Rivara FP, et al. Coagulopathy predicts poor outcome following head injury in children less than 16 years of age. J Neurosurg Anesthesiol. 2001;13:13–18.
   PubMed Web of Science ®Google Scholar
• Hao-Wei T, Po-Min C, Ya-Hsu Y, et al. The prolonged activated partial thromboplastin time at diagnosis indicates less favorable prognosis in IgA myeloma. Jpn J Clin Oncol. 2007;37:609–614.
   PubMed Web of Science ®Google Scholar
• Wiwanitkit V. Activated partial thromboplastin time abnormality in patients with cholangiocarcinoma. Clin Appl Thrombosis/Hemostasis. 2004;10:69.
   PubMed Web of Science ®Google Scholar
• Khorana AA, Francis CW, Eva C, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2010;113:224–324.
   Web of Science ®Google Scholar
• Dvorak HF, Nagy JA, Berse B, et al. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann NY Acad Sci. 2010;667:101–111.
   Web of Science ®Google Scholar
• Son HJ, Park JW, Chang HJ, et al. Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer. Ann Surg Oncol. 2013;20:2908–2913.
   PubMed Web of Science ®Google Scholar
• Ghezzi F, Cromi A, Siesto G, et al. Prognostic significance of preoperative plasma fibrinogen in endometrial cancer. Gynecol Oncol. 2010;119:309–313.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu H, Shao N, et al. The clinical significance of preoperative plasma fibrinogen level and platelet count in resectable esophageal squamous cell carcinoma. World J Surg Oncol. 2015;13:157.
   PubMed Web of Science ®Google Scholar
• Pichler M, Hutterer GC, Stojakovic T, et al. High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients. Br J Cancer. 2013;109:1123–1129.
   PubMed Web of Science ®Google Scholar
• Wakatsuki K, Matsumoto S, Migita K, et al. Preoperative plasma fibrinogen is associated with lymph node metastasis and predicts prognosis in resectable esophageal cancer. World J Surg. 2017;41:2068–2077.
   PubMed Web of Science ®Google Scholar
• Steinbrecher KA, Horowitz NA, Blevins EA, et al. Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen. Cancer Res. 2010;70:2634.
   PubMed Web of Science ®Google Scholar
• Zheng S, Shen J,Y, Liu Y, et al. Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci. 2010;100:859–865.
   Web of Science ®Google Scholar
• Shu YJ, Weng H, Bao RF, et al. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study. BMC Cancer. 2014;14:566.
   PubMed Web of Science ®Google Scholar
• Rybarczyk BJ, Simpsonhaidaris PJ. Fibrinogen assembly, secretion, and deposition into extracellular matrix by MCF-7 human breast carcinoma cells. Cancer Res. 2000;60:2033–2039.
   PubMed Web of Science ®Google Scholar
• Sahni A, Simpson-Haidaris PJ, Sahni S, et al. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost. 2010;6:176–183.
   Web of Science ®Google Scholar
• Abha S, Khorana AA, Baggs RB, et al. FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis. Blood. 2006;107:126–131.
   PubMed Web of Science ®Google Scholar
• Palumbo JS, Kombrinck KW, Drew AF, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood. 2000;96:3302.
   PubMed Web of Science ®Google Scholar
• Kołodziejczyk J, Ponczek MB. The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression. Contemp Oncol. 2013;17:113–119.
   Google Scholar
• Gabazza EC, Taguchi O, Yamakami T, et al. Evaluating prethrombotic state in lung cancer using molecular markers. Chest. 1993;103:196–200.
   PubMed Web of Science ®Google Scholar
• Tomimaru Y, Yano MK, Kishi K, et al. Plasma D-dimer levels show correlation with number of lymph node metastases in patients with esophageal cancer. J Am Coll Surg. 2006;202:139–145.
   PubMed Web of Science ®Google Scholar
• Dirix LY, Salgado R, Weytjens R, et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer. 2002;86:389–395.
   PubMed Web of Science ®Google Scholar
• van Wersch JW, Tjwa MK. Coagulation/fibrinolysis balance and lung cancer. Haemostasis. 1991;21:117–123.
   PubMedGoogle Scholar
• Tanriverdi O. Predictive value of baseline plasma D-dimers for chemotherapy- induced thrombocytopenia in patients with stage III colon cancer: a pilot study. Asian Pac J Cancer Prev. 2013;14:293–297.
   PubMedGoogle Scholar
• Kohli M, Fink LM, Spencer HJ, et al. Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer. Blood Coagul Fibrinolysis. 2002;13:1–5.
   PubMed Web of Science ®Google Scholar
• Hirahara N, Matsubara T, Kawahara D, et al. Prognostic value of hematological parameters in patients undergoing esophagectomy for esophageal squamous cell carcinoma. Int J Clin Oncol. 2016;21:909–919.
   PubMed Web of Science ®Google Scholar
• Richard W, Neeraj M, Michael S, et al. Preoperative red cell distribution width in patients undergoing pulmonary resections for non-small-cell lung cancer. Eur J Cardio-Thoracic Surg. 2014;45:108–113.
   PubMed Web of Science ®Google Scholar
• Barcala FJG, Prim JMG, Rodriguez MM, et al. Platelet count: association with prognosis in lung cancer. Med Oncol. 2010;27:357–362.
   PubMed Web of Science ®Google Scholar
• Shimada H, Oohira G, Okazumi S, et al. Thrombocytosis associated with poor prognosis in patients with esophageal carcinom. J Am Coll Surg. 2004;198:737–741.
   PubMed Web of Science ®Google Scholar
• Wan S, Lai Y, Myers RE, et al. Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients. J Gastrointest Cancer. 2013;44:293–304.
   PubMedGoogle Scholar
• Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev. 2009;23:177–189.
   PubMed Web of Science ®Google Scholar
• Deva S, Brummel-Ziedins KE, Bouchard BA, et al. Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer. J Cell Physiol. 2014;229:1005–1015.
   PubMed Web of Science ®Google Scholar
• Sabrkhany S, Griffioen AW, Oude Egbrink MG. The role of blood platelets in tumor angiogenesis. Biochim Biophys Acta. 2011;1815:189–196.
   PubMed Web of Science ®Google Scholar
• Attallah AM, El-Far M, Ibrahim AR, et al. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1. Br J Biomed Sci. 2018;75:122–127.
   PubMed Web of Science ®Google Scholar